Effect of the long‐acting tachykinin NK1 receptor antagonist MEN 11467 on tracheal mucus secretion in allergic ferrets

[1]  D. Rogers.  Motor control of airway goblet cells and glands. , 2001, Respiration physiology.

[2]  D. Rogers.  Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy. , 2000, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[3]  D. Rogers,et al.  Effect of non-peptide tachykinin NK(1) receptor antagonists on non-adrenergic, non-cholinergic neurogenic mucus secretion in ferret trachea. , 1999, European journal of pharmacology.

[4]  F. Nardelli,et al.  Correlation between binding characteristics and functional antagonism in human glioma cells by tachykinin NK1 receptor antagonists. , 1999, European journal of pharmacology.

[5]  P. Barnes,et al.  Chronic obstructive pulmonary disease: new opportunities for drug development. , 1998, Trends in pharmacological sciences.

[6]  Spina.  Modulation of Sensory Nerve Function in the Airways. , 1998, Pulmonary pharmacology & therapeutics.

[7]  D. Rogers,et al.  Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin‐sensitized guinea‐pigs in vitro , 1998, British journal of pharmacology.

[8]  H. Meurs,et al.  Involvement of tachykinin NK1 receptor in the development of allergen-induced airway hyperreactivity and airway inflammation in conscious, unrestrained guinea pigs. , 1998, American journal of respiratory and critical care medicine.

[9]  R. Terracciano,et al.  Pharmacology of the peptidomimetic, MEN 11149, a new potent, selective and orally effective tachykinin NK1 receptor antagonist. , 1998, European journal of pharmacology.

[10]  R. Pauwels,et al.  The effect of inhaled FK224, a tachykinin NK-1 and NK-2 receptor antagonist, on neurokinin A-induced bronchoconstriction in asthmatics. , 1996, American journal of respiratory and critical care medicine.

[11]  D. Rogers,et al.  ‘Sensory‐efferent’ neural control of mucus secretion: characterization using tachykinin receptor antagonists in ferret trachea in vitro , 1994, British journal of pharmacology.

[12]  C. Bertrand,et al.  Involvement of neurogenic inflammation in antigen-induced bronchoconstriction in guinea pigs. , 1993, The American journal of physiology.

[13]  C. Bertrand,et al.  Characterization of tachykinin receptors in ferret trachea by peptide agonists and nonpeptide antagonists. , 1993, The American journal of physiology.

[14]  C. Bertrand,et al.  Role of neurogenic inflammation in antigen-induced vascular extravasation in guinea pig trachea. , 1993, Journal of immunology.

[15]  J. Mak,et al.  Tachykinin control of ferret airways: Mucus secretion, bronchoconstriction and receptor mapping , 1993, Neuropeptides.

[16]  C. Maggi,et al.  Capsaicin desensitization protects from antigen-induced bronchospasm in conscious guinea-pigs. , 1987, European journal of pharmacology.

[17]  P. Andersson.  Antigen‐Induced Bronchial Anaphylaxis in Actively Sensitized Guinea‐Pigs Pattern of Response in Relation to Immunization Regimen , 1980, Allergy.

[18]  D. Rogers,et al.  Pathophysiology of Airway Mucus Secretion in Asthma , 1998 .

[19]  D. Rogers.  Neurogenic inflammation in lung disease: Burnt out? , 1997, InflammoPharmacology.

[20]  C. Corbishley,et al.  The uptake of radiolabelled precursors of mucus glycoconjugates by secretory tissues in the feline trachea. , 1990, The Journal of physiology.

[21]  J. Nadel,et al.  Autoradiographic studies of the distribution of 35sulfate label in ferret trachea: effects of stimulation. , 1987, Experimental lung research.